NFKB1 and neoplasm: Genistein suppresses TNF-α-induced NF-κB activation as well as nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor (IκB) kinase and IκB phosphorylation resulting in an inhibition of inflammation in the tumor microenvironment [154].